Wedbush Downgrades Sionna Therapeutics (SION) to Neutral

August 10, 2026 10:42 AM

Wedbush analyst Laura Chico downgraded Sionna Therapeutics (NASDAQ: SION) from Outperform to Neutral with a price target of $5.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found